Insider Selling: HCA Healthcare (NYSE:HCA) EVP Sells 1,200 Shares of Company Stock

Key Points

• HCA Healthcare EVP Michael Schlosser sold 1,200 shares for $593,580, reducing his position by 45.4%; he retained 1,443 shares.
• HCA reported quarterly EPS of $7.22, beating the $6.65 consensus, and revenue of $19.85 billion, up 3.6% year over year.
• The company declared a quarterly dividend of $0.78 per share, equivalent to an annualized yield of about 0.6%.

HCA Healthcare, Inc. (NYSE:HCA - Get Free Report) EVP Michael Schlosser sold 1,200 shares of the stock in a transaction dated Wednesday, November 4th. The shares were sold at an average price of $494.65, for a total value of $593,580.00. Following the completion of the transaction, the executive vice president owned 1,443 shares in the company, valued at approximately $713,779.95. The trade was a 45.40% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock traded down $13.04 during trading hours on Friday, hitting $494.44. The company had a trading volume of 1,462,203 shares, compared to its average volume of 1,355,955. HCA Healthcare, Inc. has a twelve month low of $353.99 and a twelve month high of $556.52. The company has a market cap of $103.28 billion, a P/E ratio of 16.38, a price-to-earnings-growth ratio of 1.71 and a beta of 1.11. The company's 50-day moving average is $442.16 and its two-hundred day moving average is $445.10.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings data on Tuesday, October 27th. The company reported $7.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.65 by $0.57. HCA Healthcare had a negative return on equity of 198.52% and a net margin of 8.61%. The company had revenue of $19.85 billion for the quarter, compared to analyst estimates of $19.33 billion. During the same quarter last year, the company posted $6.96 earnings per share. The business's quarterly revenue was up 3.6% compared to the same quarter last year. Sell-side analysts expect that HCA Healthcare, Inc. will post 30.15 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 29th. Investors of record on Tuesday, December 15th will be paid a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Tuesday, December 15th. HCA Healthcare's dividend payout ratio (DPR) is currently 10.34%.

Key Headlines Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Investors have welcomed expectations that a Democratic-controlled Congress could provide a policy tailwind for hospitals. However, the anticipated relief is not yet enacted and still depends on legislative and funding steps. HCA Healthcare Gains Policy Tailwind
• Positive Sentiment: HCA is expanding AI tools, with its nurse handoff technology heading to 100 hospitals and ambient AI expected to reach 10,000 physicians by year-end. These deployments could support workflow efficiency. AI nurse handoff tool
• Positive Sentiment: Analyst and technical coverage is supportive: Truist reaffirmed its Buy rating, while Zacks highlighted earnings growth, price strength and a bullish moving-average signal. Truist reaffirms Buy rating Zacks stock outlook
• Neutral Sentiment: HCA completed a $6.5 billion senior notes offering. The report confirms the financing but gives limited detail on its use or effect on borrowing costs. Senior notes offering
• Neutral Sentiment: HCA’s AI chief emphasized that delaying a rollout can be appropriate, suggesting a measured approach that may limit near-term adoption while managing implementation risks. HCA AI rollout strategy
• Negative Sentiment: One report flagged potential payer pressure in HCA’s 2027 outlook, a concern for future hospital reimbursement and margins. Payer pressure outlook
• Negative Sentiment: Pomerantz LLP said it is investigating investor claims involving HCA. The announcement provides no findings, but the inquiry may create a legal overhang. Investor investigation announcement

Wall Street Analysts Forecast Growth

HCA has been the subject of several research analyst reports. Sanford C. Bernstein reissued a "market perform" rating on shares of HCA Healthcare in a report on Wednesday, July 15th. Royal Bank Of Canada raised their target price on shares of HCA Healthcare from $496.00 to $521.00 and gave the stock an "outperform" rating in a research note on Friday, October 30th. Weiss Ratings raised HCA Healthcare from a "hold (c+)" rating to a "buy (b-)" rating in a report on Thursday, October 8th. JPMorgan Chase & Co. cut their price objective on HCA Healthcare from $490.00 to $425.00 and set a "neutral" rating for the company in a research report on Thursday, August 20th. Finally, KeyCorp raised their target price on HCA Healthcare from $435.00 to $490.00 and gave the company an "overweight" rating in a report on Wednesday, October 28th. Sixteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $480.13.

Hedge Funds Weigh In On HCA Healthcare

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Money Concepts Capital Corp increased its position in HCA Healthcare by 6.7% during the third quarter. Money Concepts Capital Corp now owns 719 shares of the company's stock worth $307,000 after buying an additional 45 shares in the last quarter. Allworth Financial LP raised its position in shares of HCA Healthcare by 8.7% in the third quarter. Allworth Financial LP now owns 1,246 shares of the company's stock valued at $486,000 after buying an additional 100 shares during the last quarter. Russell Investments Group Ltd. lifted its stake in shares of HCA Healthcare by 23.2% during the third quarter. Russell Investments Group Ltd. now owns 653,234 shares of the company's stock valued at $278,823,000 after buying an additional 122,894 shares during the period. Maryland State Retirement & Pension System boosted its position in HCA Healthcare by 10.8% during the third quarter. Maryland State Retirement & Pension System now owns 8,951 shares of the company's stock worth $3,820,000 after acquiring an additional 871 shares during the last quarter. Finally, Ritholtz Wealth Management grew its stake in HCA Healthcare by 6.7% in the 3rd quarter. Ritholtz Wealth Management now owns 14,137 shares of the company's stock worth $6,033,000 after acquiring an additional 883 shares during the period. Institutional investors and hedge funds own 62.73% of the company's stock.

HCA Healthcare Company Profile

HCA Healthcare is a healthcare services company that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency treatment, surgery, diagnostic services and specialized care across areas such as cancer and cardiovascular medicine.

The company serves patients in the United States and the United Kingdom through its network of hospitals and outpatient facilities, including surgery centers, urgent care clinics and physician practices.

Founded in 1968, HCA Healthcare is headquartered in Nashville, Tennessee.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.